Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) shares shot up 3.3% during trading on Thursday . The stock traded as high as $0.9132 and last traded at $0.8649. 541,740 shares changed hands during mid-day trading, a decline of 30% from the average session volume of 768,704 shares. The stock had previously closed at $0.8371.
Analysts Set New Price Targets
A number of research analysts have weighed in on CDLX shares. Wall Street Zen downgraded Cardlytics from a “hold” rating to a “sell” rating in a report on Saturday, November 8th. Weiss Ratings restated a “sell (d-)” rating on shares of Cardlytics in a research report on Monday, December 29th. Three equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Reduce” and a consensus target price of $2.25.
View Our Latest Research Report on Cardlytics
Cardlytics Trading Up 3.3%
Cardlytics (NASDAQ:CDLX – Get Free Report) last issued its quarterly earnings results on Wednesday, November 5th. The company reported ($0.07) EPS for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.08. The firm had revenue of $52.03 million for the quarter, compared to analysts’ expectations of $56.64 million. Cardlytics had a negative return on equity of 235.70% and a negative net margin of 44.12%. On average, sell-side analysts forecast that Cardlytics, Inc. will post -1.52 EPS for the current fiscal year.
Institutional Investors Weigh In On Cardlytics
Hedge funds have recently added to or reduced their stakes in the stock. Lane Generational LLC raised its position in shares of Cardlytics by 28.0% in the 2nd quarter. Lane Generational LLC now owns 780,083 shares of the company’s stock worth $1,283,000 after purchasing an additional 170,480 shares during the last quarter. Citizens Financial Group Inc. RI purchased a new stake in Cardlytics during the 3rd quarter valued at about $1,260,000. Check Capital Management Inc. CA increased its stake in Cardlytics by 20.7% during the 2nd quarter. Check Capital Management Inc. CA now owns 74,500 shares of the company’s stock valued at $123,000 after purchasing an additional 12,800 shares in the last quarter. Boothbay Fund Management LLC purchased a new position in Cardlytics in the third quarter worth about $74,000. Finally, Quinn Opportunity Partners LLC lifted its stake in shares of Cardlytics by 900.0% in the third quarter. Quinn Opportunity Partners LLC now owns 1,100,000 shares of the company’s stock worth $2,673,000 after buying an additional 990,000 shares in the last quarter. 68.10% of the stock is owned by institutional investors.
About Cardlytics
Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.
At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.
See Also
- Five stocks we like better than Cardlytics
- The day the gold market broke
- NEW LAW: Congress Approves Setup For Digital Dollar?
- He just nailed another gold prediction …
- What a Former CIA Agent Knows About the Coming Collapse
- Your Bank Account Is No Longer Safe
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.
